Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Fraser Cummings

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|May 5, 2021
JAK1 inhibition and inflammatory bowel diseaseClare Harris, J R Fraser Cummings
Inflammatory Bowel Diseases|January 28, 2005
Clinical implications of inflammatory bowel disease genetics on phenotypeJ R Fraser Cummings, Derek P Jewell
Current Opinion in Clinical Nutrition and Metabolic Care|August 12, 2011
Nutrition and inflammatory bowel disease: primary or adjuvant therapyMark P Tighe, J R Fraser Cummings, Nadeem A Afzal
Inflammatory Bowel Diseases|April 7, 2015
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilitiesSimon R Whiteoak, Richard Felwick, Tilman Sanchez-Elsner, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 22, 2019
Adalimumab Biosimilars in Europe: An Overview of the Clinical EvidenceSalvatore Bellinvia, J R Fraser Cummings, Michael R Ardern-Jones, et al.
Nutrients|November 25, 2023
Micronutrient Status in Adult Crohn's Disease during Clinical Remission: A Systematic ReviewMartin McDonnell, Stephanie Sartain, Catherine Westoby, et al.
BMJ Open Gastroenterology|November 20, 2020
Life in lockdown: experiences of patients with IBD during COVID-19Richard James Harris, Louise Downey, Trevor R Smith, et al.
Clinical Drug Investigation|August 24, 2023
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature ReviewHéctor Corominas, David Young, J R Fraser Cummings, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2018
Review article: treating-to-target for inflammatory bowel disease-associated anaemiaLaurent Peyrin-Biroulet, Anthony Lopez, J R Fraser Cummings, et al.
Plos One|January 13, 2025
Iron deficiency and fatigue in inflammatory bowel disease: A systematic reviewStephanie Sartain, Maryam Al-Ezairej, Martin McDonnell, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|May 5, 2021
JAK1 inhibition and inflammatory bowel diseaseClare Harris, J R Fraser Cummings
Inflammatory Bowel Diseases|January 28, 2005
Clinical implications of inflammatory bowel disease genetics on phenotypeJ R Fraser Cummings, Derek P Jewell
Current Opinion in Clinical Nutrition and Metabolic Care|August 12, 2011
Nutrition and inflammatory bowel disease: primary or adjuvant therapyMark P Tighe, J R Fraser Cummings, Nadeem A Afzal
Inflammatory Bowel Diseases|April 7, 2015
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilitiesSimon R Whiteoak, Richard Felwick, Tilman Sanchez-Elsner, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 22, 2019
Adalimumab Biosimilars in Europe: An Overview of the Clinical EvidenceSalvatore Bellinvia, J R Fraser Cummings, Michael R Ardern-Jones, et al.
Nutrients|November 25, 2023
Micronutrient Status in Adult Crohn's Disease during Clinical Remission: A Systematic ReviewMartin McDonnell, Stephanie Sartain, Catherine Westoby, et al.
BMJ Open Gastroenterology|November 20, 2020
Life in lockdown: experiences of patients with IBD during COVID-19Richard James Harris, Louise Downey, Trevor R Smith, et al.
Clinical Drug Investigation|August 24, 2023
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature ReviewHéctor Corominas, David Young, J R Fraser Cummings, et al.
Alimentary Pharmacology & Therapeutics|August 3, 2018
Review article: treating-to-target for inflammatory bowel disease-associated anaemiaLaurent Peyrin-Biroulet, Anthony Lopez, J R Fraser Cummings, et al.
Plos One|January 13, 2025
Iron deficiency and fatigue in inflammatory bowel disease: A systematic reviewStephanie Sartain, Maryam Al-Ezairej, Martin McDonnell, et al.
Pageof 4